McKesson Corp. (MCK) News
Filter MCK News Items
MCK News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
MCK News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest MCK News From Around the Web
Below are the latest news stories about MCKESSON CORP that investors may wish to consider to help them evaluate MCK as an investment opportunity.
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on ItMcKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. |
Should Value Investors Buy CONMED (CNMD) Stock?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
McKesson (MCK) Gains As Market Dips: What You Should KnowMcKesson (MCK) concluded the recent trading session at $585.24, signifying a +0.83% move from its prior day's close. |
Pro-Dex Stock Skyrockets Over the Past Year: A Must Buy?Investors can consider investing in PDEX right now as the stock has done extremely well through 2024 and its prospects continue to shine. |
McKesson Stock Declines Post Divestiture of Canada-Based BusinessesMCK aims to focus on capital deployment and prioritize investments to strengthen its strategic oncology and biopharma growth platforms. |
Jim Cramer’s Take on McKesson Corporation (MCK): Bold Predictions for the FutureWe recently compiled a list of the Jim Cramer’s Bold Predictions About These 10 Healthcare Stocks. In this article, we are going to take a look at where McKesson Corporation (NYSE:MCK) stands against the other healthcare stocks Jim Cramer has made bold predictions about. Healthcare has been one of Jim Cramer’s favorite topics lately. The […] |
McKesson Corporation Completes Divestiture of Canada-Based Rexall and Well.ca BusinessesIRVING, Texas, December 31, 2024--McKesson Corporation (NYSE: MCK) reported today that on December 30, 2024 it has closed the transaction announced in September 2024 to sell its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, a Canadian private equity firm. This transaction enables the Company to focus capital deployment and prioritize investments expanding its strategic oncology and biopharma growth platforms. |
Why McKesson (MCK) is a Top Value Stock for the Long-TermWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
Investing in McKesson (NYSE:MCK) five years ago would have delivered you a 333% gainBuying shares in the best businesses can build meaningful wealth for you and your family. And we've seen some truly... |
5 Beaten-Down MedTech Stocks Set to Rebound in 2025Investors may want to take a closer look at discounted stocks, such as MCK, HAE, ARAY, LIVN and PBH, in the present market landscape. |